Medtronic (MDT)

On February 16, 2026, the mood surrounding Baxter International (NYSE: BAX) is one of cautious sobriety following a seismic shift in investor confidence. Long regarded as a defensive staple of the healthcare sector, Baxter recently saw its shares plummet by over 16% in a single trading session. This collapse followed a fourth-quarter 2025 earnings report [...]

Dividend-paying stocks tend to greatly outperform non-payers. Here are three promising dividend payers.

Earnings season is starting to slow down now, which may come as a welcome relief for some. However, we do still have some important companies due to report with Walmart, Alibaba, Newmont Mining, Medtronic, Palo Alto Networks, DoorDash and Occidental...

Positive earnings pushed Applied Materials and Rivian Automotive higher as better-than-expected inflation data helped steady markets today, Feb. 13, 2026.

Medtronic's Stealth AXiS spine surgery system wins FDA clearance, offering real-time alignment tracking and broader surgical flexibility.

Becton, Dickinson and Company (NYSE: BDX), widely known as BD, has long been a cornerstone of the global healthcare infrastructure. However, as of February 11, 2026, the company is making headlines not for its traditional stability, but for a radical transformation that has sent shockwaves through the market. Following the official completion of the multi-billion [...]

As of February 9, 2026, the medtech landscape is witnessing a pivotal shift centered around the long-awaited return of robotics to the heart of the operating room. Intuitive Surgical, Inc. (NASDAQ: ISRG), the undisputed pioneer of robotic-assisted surgery (RAS), recently secured a landmark FDA clearance for its next-generation da Vinci 5 platform, specifically for use [...]

Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5 billion combination with Waters Corporation (NYSE: WAT), effectively spinning off its Biosciences and Diagnostic Solutions units to create a more streamlined "New BD." Simultaneously, the company [...]

These companies pay very healthy dividends.

Eli Lilly is the leader in the GLP-1 space, but here's another GLP-1 stock and a medical device maker to consider.

In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The deal represents the largest acquisition for Boston Scientific in over two decades, signaling a transformative

February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left investors and analysts debating the future of high-growth medtech. For over a decade, Boston Scientific has been the gold standard for consistent execution and category [...]

Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path.

AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.

Medtronic plans to acquire heart imaging firm CathWorks for up to $585 million, expanding its digital heart care tools as the deal awaits U.S. regulatory approval.

In a move that has sent shockwaves through the healthcare sector, Boston Scientific (NYSE:BSX) has announced a definitive agreement to acquire Penumbra (NYSE:PEN) for approximately $14.5 billion. The deal, announced in mid-January and currently the talk of Wall Street as we move into February 2026, marks one

Although Medtronic has lagged behind the S&P 500 Index over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the heart of it.

In a landmark moment for the American semiconductor industry, Texas Instruments (NASDAQ: TXN) has officially commenced volume production at its state-of-the-art SM1 fab in Sherman, Texas. The facility, which began shipping its first 300mm wafers to customers in late December 2025, represents the first phase of a massive $60 billion investment strategy aimed at securing [...]

MARLBOROUGH, Mass. — In a move that has sent shockwaves through the medical technology landscape, Boston Scientific (NYSE: BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE: PEN) for an enterprise value of approximately $14.5 billion. The deal, representing Boston Scientific’s largest acquisition in over

In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced on January 15, 2026, its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately $14.5 billion. The deal represents one of the most significant consolidations in the history of the medical